Sanofi-Aventis

Sanofi-Aventis targets troubled Genzyme Corp for takeover

24 Jul 2010

Sanofi-Aventis, the world's fourth-largest pharmaceutical company by prescription sales, is in talks to buy US-based Genzyme Corporation, the world's third-largest biotechnology company

Sanofi-Aventis gearing to make US acquisition worth $20 billion: report

03 Jul 2010

Sanofi-Aventis to buy US oncology products firm TargeGen for $560 million

30 Jun 2010

Sanofi-Aventis signs global licensing pact with Metabolex for Type II diabetes drug

25 Jun 2010

Sanofi-Aventis signs $750-million microRNA therapeutics deal with Regulus

22 Jun 2010

Sanofi Aventis signs antibody research deal with Vivalis SA

09 Jun 2010

Sanofi-Aventis signs $398-million cancer drug license deal with Ascenta Therapeutics

04 Jun 2010

Sanofi-Aventis and Nichi-Iko Pharmaceutical to form generic drug JV

29 May 2010

Glenmark in $325-million drug deal with Sanofi-Aventis

03 May 2010

Under the terms of the agreement, Glenmark will receive an upfront payment as well as development, regulatory and commercial milestone payments, that could reach a total of $325 million

US court bans Sun Pharma's generic equivalent of Sanofi's eloxatin

24 Apr 2010

Sanofi-Aventis in $335-million diabetes drug deal with CureDM

08 Apr 2010

Sanofi-Aventis settles patent infringement suit with generic drug manufacturers

03 Apr 2010

Sanofi-Aventis concludes Chattem acquisition

13 Mar 2010

Sanofi-Aventis commences tender offer for Chattem

11 Jan 2010

Sanofi-aventis to acquire Chattem for $1.9 billion

21 Dec 2009

The acquisition would help the French drug firm move up a rank to the world's fifth  largest drug maker

Sanofi-Aventis signs drug localisation pact with Russia

28 Nov 2009

Sanofi-Aventis expands Regeneron research deal to $1 billion

11 Nov 2009

AstraZeneca says its new anti-clotting drug better than Plavix

31 Aug 2009

Sanofi-Aventis to acquire Merck's Merial stake for $4 billion

30 Jul 2009

Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore

27 Jul 2009

France’s biggest drug maker, Sanofi-Aventis, will acquire majority control of Indian pioneering vaccines maker Shanta Biotechnics valuing the unlisted Indian company at nearly Rs3,757 crore.

Sanofi’s diabetes drug may increase cancer risk: European study

27 Jun 2009

PPF ends opposition to Zentiva sale; Sanofi takeover likely

11 Feb 2009

Sanofi settles Allegra, Nasacort patent suits with Teva, Barr

20 Nov 2008

Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid

23 Jun 2008

French drug giant Sanofi-Aventis opens R&D centre in Goa

05 Dec 2007

View details about the software product Informachine News Trackers